The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan
Abstract
AIMS: Theoretically, bioresorbable vascular scaffolds (BVSs) may provide superior long-term results compared with permanent metallic drug-eluting stents (DESs). However, whether BVSs are as safe and effective as metallic DESs prior to complete bioresorption is unknown. METHODS AND RESULTS: ABSORB Japan was a single-blind, multicentre, active-controlled, randomized trial designed to support regulatory approval of the Absorb BVS in Japan. Eligible patients with one or two de novo lesions in different epicardial vessels were randomized at 38 Japanese sites in a 2:1 ratio to Absorb BVS vs. cobalt-chromium everolimus-eluting stents (CoCr-EESs). The primary endpoint was target lesion failure [TLF: a composite of cardiac death, myocardial infarction attributable to target vessel, or ischaemia-driven target lesion revascularization (ID-TLR)] at 12 months, powered for non-inferiority. The major secondary endpoint was angiographic in-segment late lumen loss (LLL) at 13 months. A total of 400 patients were randomized to BVSs (266 patients and 275 lesions) or CoCr-EESs (134 patients and 137 lesions). TLF through 12 months was 4.2% with BVSs and 3.8% with CoCr-EESs [difference (upper one-sided 95% confidence limit) = 0.39% (3.95%); Pnon-inferiority < 0.0001]. Definite/probable stent/scaffold thrombosis at 12 months occurred in 1.5% of the patients with both devices (P = 1.0), and ID-TLR for restenosis was infrequent (1.1% with BVSs and 1.5% with CoCr-EESs, P = 1.0). With 96.0% angiographic follow-up, in-segment LLL at 13 months was 0.13 ± 0.30 mm with BVSs and 0.12 ± 0.32 mm with CoCr-EESs [difference (upper one-sided 95% confidence limit) = 0.01 (0.07); Pnon-inferiority < 0.0001). CONCLUSION: In the ABSORB Japan randomized trial, 12-month clinical and 13-month angiographic outcomes of BVSs were comparable to CoCr-EESs. CLINICAL REGISTRATION: ClinicalTrials.gov, number NCT01844284.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
Self-citationSome Methods for Strengthening the Common χ 2 Tests
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001616 · Cited by 3,718
Palmerini, T., Biondi-Zoccai, G., Riva, D. D., Stettler, C., Sangiorgi, D., D'Ascenzo, F., Kimura, T., Briguori, C., Sabatè, M., Kim, H.-S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60324-9 · Cited by 959
Self-citationOrmiston, J. A., Serruys, P. W., Regar, E., Dudek, D., Thuesen, L., Webster, M. W., Onuma, Y., Garcia-Garcia, H. M., McGreevy, R., & Veldhof, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60415-8 · Cited by 712
Self-citationFarrington, C. P., & Manning, G. (1990) · Statistics in Medicine · doi:10.1002/sim.4780091208 · Cited by 657
Moussa, I. D., Klein, L. W., Shah, B., Mehran, R., Mack, M. J., Brilakis, E. S., Reilly, J. P., Zoghbi, G., Holper, E., & Stone, G. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.720 · Cited by 650
Self-citationSerruys, P. W., Chevalier, B., Dudek, D., Cequier, A., Carrié, D., Iniguez, A., Dominici, M., van der Schaaf, R. J., Haude, M., Wasungu, L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61455-0 · Cited by 564
Self-citationCapodanno, D., Gori, T., Nef, H., Latib, A., Mehilli, J., Lesiak, M., Caramanno, G., Naber, C., Di Mario, C., Colombo, A., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m07_11 · Cited by 452
Kimura, T., Morimoto, T., Nakagawa, Y., Kawai, K., Miyazaki, S., Muramatsu, T., Shiode, N., Namura, M., Sone, T., Oshima, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.046599 · Cited by 268
Self-citationSerruys, P. W., Onuma, Y., Garcia-Garcia, H. M., Muramatsu, T., van Geuns, R.-J., de Bruyne, B., Dudek, D., Thuesen, L., Smits, P. C., Chevalier, B., et al. (2014) · EuroIntervention · doi:10.4244/eijv9i11a217 · Cited by 239
Self-citation
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · EuroIntervention · doi:10.4244/eijy19m01_01 · Cited by 1,259
2018 ESC/EACTS Guidelines on myocardial revascularization
Sousa-Uva, M., Neumann, F.-J., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy289 · Cited by 989
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
Ellis, S. G., Kereiakes, D. J., Metzger, D. C., Caputo, R. P., Rizik, D. G., Teirstein, P. S., Litt, M. R., Kini, A., Kabour, A., Marx, S. O., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509038 · Cited by 630
Self-citationCassese, S., Byrne, R. A., Ndrepepa, G., Kufner, S., Wiebe, J., Repp, J., Schunkert, H., Fusaro, M., Kimura, T., & Kastrati, A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00979-4 · Cited by 369
Self-citation
Metadata
- Authors
- Kimura, T., Kozuma, K., Tanabe, K., Nakamura, S., Yamane, M., Muramatsu, T., Saito, S., Yajima, J., Hagiwara, N., Mitsudo, K., Popma, J. J., Serruys, P. W., Onuma, Y., Ying, S., Cao, S., Staehr, P., Cheong, W.-F., Kusano, H., & Stone, G. W.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09-01
- Volume
- 36
- Issue
- 47
- Pages
- 3332-3342
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W1918239401
- Cited by
- 274
- References
- 15
- FWCI
- 59.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. https://app.cochat.ai/papers/10.1093/eurheartj/ehv435
- The paper
- Kimura, T., Kozuma, K., Tanabe, K., Nakamura, S., Yamane, M., Muramatsu, T., Saito, S., Yajima, J., Hagiwara, N., Mitsudo, K., Popma, J. J., Serruys, P. W., Onuma, Y., Ying, S., Cao, S., Staehr, P., Cheong, W.-F., Kusano, H., & Stone, G. W. (2015). A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv435
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.